GlucoTrack, Inc. GCTK

Set alert

Price alert · GCTK

All alert types
0.49 USD -0.31 -38.75%

As of Nov 2, 3:47 PM ET

Bid
1.35 × 22,500
Ask
1.38 × 2,000
0.49 Day range 0.7604
0.49 52-week range 207.00
YTD
-99.58%
1 year
-99.75%
Open
0.76
Prev close
0.80
Mkt cap
580.22K
Vol
73.95K
Avg vol
1.90M
EPS
-149.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.49
High
0.7604
Forward P/E
0.00
Beta
0.16
Short ratio
6.03
Inst. own
0.95%
Dividend
0.00
Ex-div date
50-d avg
0.97332
200-d avg
1.89
1y target
0.00

1D chart

Chart tools
Interval

Signals (34)
NameTimeAgo
SMA: Bearish3:29 PM10 hours ago
SMA: Bearish3:29 PM10 hours ago
MACD: Sell Signal3:29 PM10 hours ago
RSI: Oversold3:29 PM10 hours ago
MACD: Buy Signal3:02 PM10 hours ago
MACD: Sell Signal2:51 PM10 hours ago
MACD: Buy Signal1:01 PM12 hours ago
SMA: Bearish12:45 PM12 hours ago
SMA: Bearish12:45 PM12 hours ago
RSI: Oversold12:45 PM12 hours ago
MACD: Sell Signal12:44 PM12 hours ago
SMA: Bullish12:27 PM13 hours ago
SMA: Bullish12:27 PM13 hours ago
MACD: Buy Signal12:27 PM13 hours ago
RSI: Overbought12:27 PM13 hours ago
SMA: Bearish12:14 PM13 hours ago
RSI: Oversold12:14 PM13 hours ago
MACD: Sell Signal11:56 AM13 hours ago
SMA: Bullish11:41 AM13 hours ago
RSI: Overbought11:41 AM13 hours ago

Newest 20 of 34.

Key statistics

Market cap
3.83M
Enterprise value
1.60M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.35
EPS (TTM)
-2.91
Beta
0.16
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-4.69M
Total cash
159.00K
Total debt
274.00K
Return on equity
-541.13%
Shares outstanding
14.49M
Short % of float
0.83%
50-day average
0.97332
200-day average
1.89

Financials — quick view

All financials
GCTK Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GCTK Net income — quarterly -3.81M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GCTK EPS — quarterly -22.80
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on GCTK — it syncs with the Stock Master app.

Insider holders

GCTK insider holders
InsiderRelationLatest transactionDateShares held
SYCOFF ANDREWDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseApr 21, 20242,951,260

Institution ownership

GCTK institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.47%27,1617.17KSep 29, 2024
Alerus Financial NA0.24%13,8553.66KSep 29, 2024
Cetera Investment Advisers0.17%10,0002.64KSep 29, 2024
UBS Group AG0.05%3,085814Sep 29, 2024
Tower Research Capital LLC (TRC)0.01%432114Sep 29, 2024
Morgan Stanley0.01%500131Sep 29, 2024

Fund ownership

GCTK fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.37%21,6135.71KOct 30, 2024
Fidelity Series Total Market Index Fund0.09%5,0641.34KOct 30, 2024